Healius Ltd (AU:HLS) — Market Cap & Net Worth
Market Cap & Net Worth: Healius Ltd (HLS)
Healius Ltd (AU:HLS) has a market capitalization of $192.68 Million (AU$272.31 Million) as of August 1, 2026. Listed on the AU stock exchange, this Australia-based company holds position #16622 globally and #466 in its home market, demonstrating a 7.14% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Healius Ltd's stock price AU$0.38 by its total outstanding shares 726155821 (726.16 Million). See Healius Ltd capital spending ratio to understand how much of operating cash flow is reinvested back into capital assets.
Healius Ltd Market Cap History: 2015 to 2026
Healius Ltd's market capitalization history from 2015 to 2026. Data shows change from $878.40 Million to $192.68 Million (-17.14% CAGR).
Index Memberships
Healius Ltd is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Australia All Ordinaries
AORD
|
$2.03 Trillion | 0.01% | #283 of 495 |
|
S&P/ASX All Australian 200
AXAT
|
$1.94 Trillion | 0.01% | #185 of 200 |
|
S&P/ASX 200
AXJO
|
$1.91 Trillion | 0.01% | #161 of 200 |
|
S&P/ASX 200 Accumulated
AXJOA
|
$1.91 Trillion | 0.01% | #161 of 200 |
|
S&P/ASX 300
AXKO
|
$2.17 Trillion | 0.01% | #253 of 300 |
|
ASX Small Ordinaries
AXSO
|
$290.35 Billion | 0.07% | #161 of 200 |
Weight: Healius Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Healius Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Healius Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.35x
Healius Ltd's market cap is 0.35 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.58 Billion | $1.61 Billion | $38.40 Million | 0.98x | 41.13x |
| 2017 | $1.45 Billion | $1.66 Billion | -$516.80 Million | 0.87x | N/A |
| 2018 | $955.11 Million | $1.74 Billion | $4.10 Million | 0.55x | 232.95x |
| 2019 | $1.21 Billion | $1.57 Billion | $55.30 Million | 0.77x | 21.91x |
| 2020 | $1.66 Billion | $1.58 Billion | -$70.50 Million | 1.04x | N/A |
| 2021 | $2.41 Billion | $1.90 Billion | $43.70 Million | 1.27x | 55.24x |
| 2022 | $1.46 Billion | $2.29 Billion | $307.90 Million | 0.64x | 4.74x |
| 2023 | $840.07 Million | $1.71 Billion | -$367.80 Million | 0.49x | N/A |
| 2024 | $703.91 Million | $1.75 Billion | -$645.80 Million | 0.40x | N/A |
| 2025 | $464.99 Million | $1.34 Billion | -$151.20 Million | 0.35x | N/A |
Competitor Companies of HLS by Market Capitalization
Companies near Healius Ltd in the global market cap rankings as of August 1, 2026.
Key companies related to Healius Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $215.77 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #169 globally with a market cap of $137.72 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #577 globally with a market cap of $46.48 Billion USD ( CN¥317.64 Billion CNY).
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #616 globally with a market cap of $43.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $215.77 Billion | $574.30 |
| #169 | Danaher Corporation | NYSE:DHR | $137.72 Billion | $194.98 |
| #577 | WuXi AppTec Co Ltd | SHG:603259 | $46.48 Billion | CN¥128.43 |
| #616 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.83 Billion | $559.07 |
Healius Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Healius Ltd's market cap moved from $878.40 Million to $ 192.68 Million, with a yearly change of -17.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$192.68 Million | -58.56% |
| 2025 | AU$464.99 Million | -33.94% |
| 2024 | AU$703.91 Million | -16.21% |
| 2023 | AU$840.07 Million | -42.46% |
| 2022 | AU$1.46 Billion | -39.53% |
| 2021 | AU$2.41 Billion | +45.80% |
| 2020 | AU$1.66 Billion | +36.64% |
| 2019 | AU$1.21 Billion | +26.88% |
| 2018 | AU$955.11 Million | -33.96% |
| 2017 | AU$1.45 Billion | -8.43% |
| 2016 | AU$1.58 Billion | +79.78% |
| 2015 | AU$878.40 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Healius Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $192.68 Million USD |
| MoneyControl | $192.68 Million USD |
| MarketWatch | $192.68 Million USD |
| marketcap.company | $192.68 Million USD |
| Reuters | $192.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Healius Ltd
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more